StonvexLoading…
StonvexStonvexStonvexCore line items from BABB's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-02-28 | Annual 2025 2025-11-30 | Q3 2025 2025-08-31 | Q2 2025 2025-05-31 |
|---|---|---|---|---|
Revenue | $723.66K | $3.44M | $2.33M | $1.57M |
Operating Income | $152.75K | $721.63K | $566.77K | $347.94K |
Net Income | $119.17K | $559.04K | $438.19K | $270.56K |
EPS (Diluted) | $0.02 | $0.08 | $0.06 | $0.02 |
Total Assets | $4.77M | $4.78M | $4.92M | $4.77M |
Total Liabilities | $1.33M | $1.32M | $1.50M | $1.45M |
Cash & Equivalents | $2.11M | $2.15M | $2.03M | $2.05M |
Free Cash Flow OCF − CapEx | Not available | Not available | $452.06K | Not available |
Shares Outstanding | 7.26M | 7.26M | 7.26M | 7.26M |